Previous Patent Infringement Contentions and Expert Testimony May Inform the Scope of Subsequent Allegations

Jun 8, 2020

Reading Time : 3 min

In 2016, Oyster Optics, LLC (“Oyster”) brought patent infringement actions against Fujitsu Limited (“Fujitsu”), Fujitsu Network Communications, Inc. (FNC), Alcatel-Lucent USA, Inc. (ALU), and Cisco Systems, Inc. (“Cisco”) in the Eastern District of Texas, alleging infringement of U.S. Patent No. 7,620,327 (“the ’327 Patent”). The ’327 Patent is directed to transceiver cards for sending and receiving data over a fiber optic network, and Oyster’s allegations against Fujitsu and FNC were directed towards Fujitsu’s modulators and integrated receivers, among other products. Oyster’s actions against ALU and Cisco were based on their sales of products which contained Fujitsu modulators and receivers. The ALU and Cisco actions were eventually consolidated with Oyster’s action against FNC.

In 2018, Oyster settled its action against FNC, and entered into the Oyster/Fujitsu Agreement (“Agreement”). By the terms of the Agreement, Oyster agreed to release “FNC, Fujitsu, and their Affiliates” from claims of patent infringement of the ’327 Patent. Additionally, the Agreement extended Oyster’s release to FNC’s customers for claims of infringement of the ’327 Patent directed towards “Licensed Products,” a term defined by the Agreement as products “made, sold, imported, or distributed by FNC, [Fujitsu], or their Affiliates.” The definition of Licensed Products further clarified that it did not prevent Oyster from exercising its patent rights directed towards Licensed Products not substantially embodying the essential features of the ’327 Patent. The Agreement also granted Fujitsu, FNC, and their Affiliates a forward-looking license to the ’327 Patent.

As a result of the Agreement, ALU and Cisco moved for summary judgement, arguing that the Agreement released them—as customers of FNC/Fujitsu—of all claims of infringement directed to products containing Fujitsu modulators and receivers. The district court granted the motion, reasoning that the Agreement’s provision regarding Oyster’s ability to exercise its patent rights against products not substantially embodying the essential features of the ’327 Patent applied only to the forward-looking license and not to the release of infringement claims. The district court also held, in the alternative, that the Agreement released ALU and Cisco from liability because the accused ALU and Cisco products embodied the essential features of the ’327 Patent.

The Federal Circuit resolved the appeal on the basis of the district court’s alternative ruling. Hence, the primary question on appeal was whether the Fujitsu modulators and receivers incorporated into the accused ALU and Cisco products substantially embodied the essential features of the ’327 Patent. Oyster argued that the Fujitsu modulators and receivers did not substantially embody the essential features of the ’327 Patent because the claims of the ’327 Patent were directed to a transceiver card, requiring components in addition to a modulator and a receiver. Furthermore, Oyster contended that its allegations of infringement against Fujitsu and FNC directed to modulators and receivers were based only on indirect infringement. The Federal Circuit, however, upheld the district court’s holding that the accused ALU and Cisco products did indeed substantially embody the essential features of the ’327 Patent. The Federal Circuit reached this conclusion based on Oyster’s previous infringement contentions and expert testimony, which repeatedly alleged infringement of the ’327 Patent by the Fujitsu modulators and receivers. For example, Oyster specifically named the Fujitsu modulators and receivers as products accused of infringing the ’327 Patent in previous litigation, and Oyster’s expert gave testimony on Fujitsu modulators and receivers to the same effect.

Oyster Optics, LLC v. Alcatel-Lucent USA, Inc., 2019-1255, 2019-1257 (Fed. Cir. May 27, 2020).

Practice Tip: A party’s allegations, infringement contentions, and expert testimony regarding patent infringement may be used by a court to define or limit the scope of different allegations across related litigations. Thus, when litigating the same patent against different parties, practitioners should be cognizant that infringement allegations made in one proceeding may inform a court’s determinations in related or subsequent proceedings.

Share This Insight

Previous Entries

IP Newsflash

December 18, 2025

The Federal Circuit recently vacated a $20 million jury verdict in favor of a patentee and remanded with instructions to dismiss the case for lack of subject matter jurisdiction, finding that the patentee did not own the asserted patents at the time it filed suit and therefore lacked standing.

...

Read More

IP Newsflash

December 17, 2025

The Federal Circuit recently affirmed a Patent Trial and Appeal Board decision finding claims that had been subject to an ex parte reexamination unpatentable. As a threshold issue, the court held that IPR estoppel under 35 USC § 315(e)(1) does not apply to ongoing ex parte reexaminations. Accordingly, the Patent Office did not err in continuing the reexamination after issuing final written decisions in co-pending IPRs.

...

Read More

IP Newsflash

December 15, 2025

The District of Delaware recently denied a defendant’s motion to dismiss plaintiff’s demand for enhanced damages based on willful infringement pursuant to 35 U.S.C. § 284, explaining that neither a demand for damages under § 284 nor an accusation of willful infringement amount to a claim for relief that can be subject to dismissal under Rule 12(b)(6).

...

Read More

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.